ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
This Quarter Return
-18.92%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$189M
AUM Growth
+$189M
(-16%)
Cap. Flow
-$10M
Cap. Flow
% of AUM
-5.3%
Top 10 Holdings %
Top 10 Hldgs %
53.49%
Holding
84
New
11
Increased
22
Reduced
15
Closed
36
Top Buys
| 1 |
Zimmer Biomet
ZBH
|
$8.75M |
| 2 |
IIN
IntriCon Corporation
IIN
|
$5.61M |
| 3 |
AGN
Allergan plc
AGN
|
$5.42M |
| 4 |
Encompass Health
EHC
|
$5.26M |
| 5 |
MDRX
Veradigm Inc. Common Stock
MDRX
|
$4.96M |
Top Sells
| 1 |
TVTY
Tivity Health, Inc. Common Stock
TVTY
|
$9.99M |
| 2 |
SHPG
Shire pic
SHPG
|
$7.67M |
| 3 |
Abbott
ABT
|
$5.78M |
| 4 |
Merck
MRK
|
$5.68M |
| 5 |
Baxter International
BAX
|
$5.26M |
Sector Composition
| 1 | Healthcare | 91.46% |
| 2 | Industrials | 3.75% |
| 3 | Technology | 3.46% |
| 4 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGN
1
DELISTED
Allergan plc
AGN
| $15.9M | 8.41% | 119,071 +40,551 | +52% | +$5.42M |
|
2
Cigna
CI
$80.3B
| $13.5M | 7.12% | 70,944 -11,870 | -14% | -$2.25M |
|
|
3
Zimmer Biomet
ZBH
$21B
| $12.9M | 6.79% | 123,905 +84,341 | +213% | +$8.75M |
|
|
CELG
4
DELISTED
Celgene Corp
CELG
| $10.8M | 5.71% | 168,609 +70,208 | +71% | +$4.5M |
|
5
CVS Health
CVS
$92.8B
| $9.67M | 5.11% | 147,629 +56,211 | +61% | +$3.68M |
|
6
Medtronic
MDT
$119B
| $8.44M | 4.46% | 92,827 +27,698 | +43% | +$2.52M |
|
|
SHPG
7
DELISTED
Shire pic
SHPG
| $8.02M | 4.24% | 46,100 -44,043 | -49% | -$7.67M |
|
|
WMGI
8
DELISTED
Wright Medical Group Inc
WMGI
| $7.68M | 4.06% | 282,108 -25,108 | -8% | -$683K |
|
9
DaVita
DVA
$9.85B
| $7.24M | 3.83% | 140,729 +70,639 | +101% | +$3.64M |
|
|
RCM
10
DELISTED
R1 RCM Inc. Common Stock
RCM
| $7.1M | 3.75% | 893,421 +425,958 | +91% | +$3.39M |
|
|
IIN
11
DELISTED
IntriCon Corporation
IIN
| $6.54M | 3.46% | 247,980 +212,486 | +599% | +$5.61M |
|
|
OXFD
12
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $5.9M | 3.12% | 461,234 +166,005 | +56% | +$2.12M |
|
|
MDRX
13
DELISTED
Veradigm Inc. Common Stock
MDRX
| $5.7M | 3.01% | 591,533 +515,039 | +673% | +$4.96M |
|
14
Hologic
HOLX
$14.9B
| $5.58M | 2.95% | 135,805 +42,760 | +46% | +$1.76M |
|
15
Icon
ICLR
$13.8B
| $5.32M | 2.81% | 41,132 +25,033 | +155% | +$3.23M |
|
|
16
Encompass Health
EHC
$12.3B
| $5.26M | 2.78% | +85,272 | New | +$5.26M |
|
17
Dentsply Sirona
XRAY
$2.85B
| $4.41M | 2.33% | +118,424 | New | +$4.41M |
|
18
UnitedHealth
UNH
$281B
| $4.17M | 2.2% | 16,732 +9,810 | +142% | +$2.44M |
|
19
Sanofi
SNY
$121B
| $3.53M | 1.87% | 81,401 -51,844 | -39% | -$2.25M |
|
20
Insulet
PODD
$23.9B
| $3.23M | 1.71% | +40,727 | New | +$3.23M |
|
21
Bausch Health
BHC
$2.74B
| $3.03M | 1.6% | 163,908 -533 | -0.3% | -$9.84K |
|
22
Iovance Biotherapeutics
IOVA
$807M
| $2.82M | 1.49% | 318,185 +76,016 | +31% | +$673K |
|
23
Bristol-Myers Squibb
BMY
$96B
| $2.57M | 1.36% | 49,337 -28,634 | -37% | -$1.49M |
|
24
Sarepta Therapeutics
SRPT
$1.78B
| $2.36M | 1.25% | 21,615 +13,159 | +156% | +$1.44M |
|
|
NVRO
25
DELISTED
NEVRO CORP.
NVRO
| $2.14M | 1.13% | 54,977 +30,806 | +127% | +$1.2M |
|